APO Research
Talk to an analyst

APO RESEARCH · REPORT

Celecoxib

Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.

The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.

Selected research

Market Analysis & Forecast

Global Celecoxib Market Analysis and Forecast 2026-2032

30 December 2025197 pages

Choose your research edition.

Industry ResearchCelecoxib Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Celecoxib Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Celecoxib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Celecoxib Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Celecoxib Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.

The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.

Data show that more than 400 million people worldwide are currently affected by joint diseases.

Read the full market overview

The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.

The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.

At present, the burden of chronic diseases will increase by 40% due to the aging of the population.

As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.

Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.

At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.

At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.

It accounted for 63.39% of the global market in 2019.

As of 2019, China relies entirely on Pfizer for celecoxib imports.

Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.

This report presents an overview of global market for Celecoxib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Celecoxib, also provides the sales of main regions and countries. Of the upcoming market potential for Celecoxib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Celecoxib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Celecoxib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Celecoxib sales, projected growth trends, production technology, application and end-user industry.

Celecoxib Segment by Company

Pfizer Inc

Teva

Mylan

Apotex

Lupin

Hengrui Medicine

Celecoxib Segment by Type

50mg

100mg

200mg

400mg

Celecoxib Segment by Application

Rheumatoid arthritis

osteoarthritis

Acute pain

Musculoskeletal pain

Other diseases

Celecoxib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Celecoxib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Celecoxib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Celecoxib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Celecoxib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Celecoxib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Celecoxib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Celecoxib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 50mg Major Manufacturers Table 3. 100mg Major Manufacturers Table 4. 200mg Major Manufacturers Table 5. 400mg Major Manufacturers Table 6. Global Celecoxib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Rheumatoid arthritis Major Manufacturers Table 8. osteoarthritis Major Manufacturers Table 9. Acute pain Major Manufacturers Table 10. Musculoskeletal pain Major Manufacturers Table 11. Other diseases Major Manufacturers Table 12. Celecoxib Industry Trends Table 13. Celecoxib Industry Drivers Table 14. Celecoxib Industry Opportunities and Challenges Table 15. Celecoxib Industry Restraints Table 16. Global Celecoxib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Celecoxib Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Celecoxib Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Celecoxib Revenue Market Share by Region (2021-2026) Table 20. Global Celecoxib Revenue Market Share by Region (2027-2032) Table 21. Global Celecoxib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 22. Global Celecoxib Sales by Region (2021-2026) & (K Units) Table 23. Global Celecoxib Sales by Region (2027-2032) & (K Units) Table 24. Global Celecoxib Sales Market Share by Region (2021-2026) Table 25. Global Celecoxib Sales Market Share by Region (2027-2032) Table 26. Global Celecoxib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Celecoxib Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Celecoxib Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Celecoxib Sales Market Share by Manufacturers (2021-2026) Table 30. Global Celecoxib Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Celecoxib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Celecoxib Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Celecoxib Manufacturers, Product Type & Application Table 34. Global Celecoxib Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Celecoxib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Celecoxib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Celecoxib Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Celecoxib Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Celecoxib Revenue Market Share by Type (2021-2026) Table 41. Global Celecoxib Revenue Market Share by Type (2027-2032) Table 42. Global Celecoxib Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 43. Global Celecoxib Sales by Type (2021-2026) & (K Units) Table 44. Global Celecoxib Sales by Type (2027-2032) & (K Units) Table 45. Global Celecoxib Sales Market Share by Type (2021-2026) Table 46. Global Celecoxib Sales Market Share by Type (2027-2032) Table 47. Global Celecoxib Price by Type (2021-2026) & (US$/Unit) Table 48. Global Celecoxib Price by Type (2027-2032) & (US$/Unit) Table 49. Global Celecoxib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Celecoxib Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Celecoxib Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Celecoxib Revenue Market Share by Application (2021-2026) Table 53. Global Celecoxib Revenue Market Share by Application (2027-2032) Table 54. Global Celecoxib Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 55. Global Celecoxib Sales by Application (2021-2026) & (K Units) Table 56. Global Celecoxib Sales by Application (2027-2032) & (K Units) Table 57. Global Celecoxib Sales Market Share by Application (2021-2026) Table 58. Global Celecoxib Sales Market Share by Application (2027-2032) Table 59. Global Celecoxib Price by Application (2021-2026) & (US$/Unit) Table 60. Global Celecoxib Price by Application (2027-2032) & (US$/Unit) Table 61. Pfizer Inc Company Information Table 62. Pfizer Inc Business Overview Table 63. Pfizer Inc Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Pfizer Inc Celecoxib Product Portfolio Table 65. Pfizer Inc Recent Development Table 66. Teva Company Information Table 67. Teva Business Overview Table 68. Teva Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Teva Celecoxib Product Portfolio Table 70. Teva Recent Development Table 71. Mylan Company Information Table 72. Mylan Business Overview Table 73. Mylan Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Mylan Celecoxib Product Portfolio Table 75. Mylan Recent Development Table 76. Apotex Company Information Table 77. Apotex Business Overview Table 78. Apotex Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Apotex Celecoxib Product Portfolio Table 80. Apotex Recent Development Table 81. Lupin Company Information Table 82. Lupin Business Overview Table 83. Lupin Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Lupin Celecoxib Product Portfolio Table 85. Lupin Recent Development Table 86. Hengrui Medicine Company Information Table 87. Hengrui Medicine Business Overview Table 88. Hengrui Medicine Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Hengrui Medicine Celecoxib Product Portfolio Table 90. Hengrui Medicine Recent Development Table 91. North America Celecoxib Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Celecoxib Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Celecoxib Sales by Type (2021-2026) & (K Units) Table 94. North America Celecoxib Sales by Type (2027-2032) & (K Units) Table 95. North America Celecoxib Sales Price by Type (2021-2026) & (US$/Unit) Table 96. North America Celecoxib Sales Price by Type (2027-2032) & (US$/Unit) Table 97. North America Celecoxib Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Celecoxib Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Celecoxib Sales by Application (2021-2026) & (K Units) Table 100. North America Celecoxib Sales by Application (2027-2032) & (K Units) Table 101. North America Celecoxib Sales Price by Application (2021-2026) & (US$/Unit) Table 102. North America Celecoxib Sales Price by Application (2027-2032) & (US$/Unit) Table 103. North America Celecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Celecoxib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. North America Celecoxib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. North America Celecoxib Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 107. North America Celecoxib Sales by Country (2021-2026) & (K Units) Table 108. North America Celecoxib Sales by Country (2027-2032) & (K Units) Table 109. North America Celecoxib Sales Price by Country (2021-2026) & (US$/Unit) Table 110. North America Celecoxib Sales Price by Country (2027-2032) & (US$/Unit) Table 111. United States Celecoxib Revenue (2021-2032) & (US$ Million) Table 112. Canada Celecoxib Revenue (2021-2032) & (US$ Million) Table 113. Mexico Celecoxib Revenue (2021-2032) & (US$ Million) Table 114. Europe Celecoxib Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe Celecoxib Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe Celecoxib Sales by Type (2021-2026) & (K Units) Table 117. Europe Celecoxib Sales by Type (2027-2032) & (K Units) Table 118. Europe Celecoxib Sales Price by Type (2021-2026) & (US$/Unit) Table 119. Europe Celecoxib Sales Price by Type (2027-2032) & (US$/Unit) Table 120. Europe Celecoxib Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Celecoxib Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Celecoxib Sales by Application (2021-2026) & (K Units) Table 123. Europe Celecoxib Sales by Application (2027-2032) & (K Units) Table 124. Europe Celecoxib Sales Price by Application (2021-2026) & (US$/Unit) Table 125. Europe Celecoxib Sales Price by Application (2027-2032) & (US$/Unit) Table 126. Europe Celecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Celecoxib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 128. Europe Celecoxib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 129. Europe Celecoxib Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 130. Europe Celecoxib Sales by Country (2021-2026) & (K Units) Table 131. Europe Celecoxib Sales by Country (2027-2032) & (K Units) Table 132. Europe Celecoxib Sales Price by Country (2021-2026) & (US$/Unit) Table 133. Europe Celecoxib Sales Price by Country (2027-2032) & (US$/Unit) Table 134. Germany Celecoxib Revenue (2021-2032) & (US$ Million) Table 135. France Celecoxib Revenue (2021-2032) & (US$ Million) Table 136. U.K. Celecoxib Revenue (2021-2032) & (US$ Million) Table 137. Italy Celecoxib Revenue (2021-2032) & (US$ Million) Table 138. Russia Celecoxib Revenue (2021-2032) & (US$ Million) Table 139. Spain Celecoxib Revenue (2021-2032) & (US$ Million) Table 140. Netherlands Celecoxib Revenue (2021-2032) & (US$ Million) Table 141. Switzerland Celecoxib Revenue (2021-2032) & (US$ Million) Table 142. Sweden Celecoxib Revenue (2021-2032) & (US$ Million) Table 143. Poland Celecoxib Revenue (2021-2032) & (US$ Million) Table 144. China Celecoxib Revenue by Type (2021-2026) & (US$ Million) Table 145. China Celecoxib Revenue by Type (2027-2032) & (US$ Million) Table 146. China Celecoxib Sales by Type (2021-2026) & (K Units) Table 147. China Celecoxib Sales by Type (2027-2032) & (K Units) Table 148. China Celecoxib Sales Price by Type (2021-2026) & (US$/Unit) Table 149. China Celecoxib Sales Price by Type (2027-2032) & (US$/Unit) Table 150. China Celecoxib Revenue by Application (2021-2026) & (US$ Million) Table 151. China Celecoxib Revenue by Application (2027-2032) & (US$ Million) Table 152. China Celecoxib Sales by Application (2021-2026) & (K Units) Table 153. China Celecoxib Sales by Application (2027-2032) & (K Units) Table 154. China Celecoxib Sales Price by Application (2021-2026) & (US$/Unit) Table 155. China Celecoxib Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Asia Celecoxib Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia Celecoxib Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia Celecoxib Sales by Type (2021-2026) & (K Units) Table 159. Asia Celecoxib Sales by Type (2027-2032) & (K Units) Table 160. Asia Celecoxib Sales Price by Type (2021-2026) & (US$/Unit) Table 161. Asia Celecoxib Sales Price by Type (2027-2032) & (US$/Unit) Table 162. Asia Celecoxib Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia Celecoxib Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia Celecoxib Sales by Application (2021-2026) & (K Units) Table 165. Asia Celecoxib Sales by Application (2027-2032) & (K Units) Table 166. Asia Celecoxib Sales Price by Application (2021-2026) & (US$/Unit) Table 167. Asia Celecoxib Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Asia Celecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Asia Celecoxib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Asia Celecoxib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Asia Celecoxib Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 172. Asia Celecoxib Sales by Country (2021-2026) & (K Units) Table 173. Asia Celecoxib Sales by Country (2027-2032) & (K Units) Table 174. Asia Celecoxib Sales Price by Country (2021-2026) & (US$/Unit) Table 175. Asia Celecoxib Sales Price by Country (2027-2032) & (US$/Unit) Table 176. Japan Celecoxib Revenue (2021-2032) & (US$ Million) Table 177. South Korea Celecoxib Revenue (2021-2032) & (US$ Million) Table 178. India Celecoxib Revenue (2021-2032) & (US$ Million) Table 179. Australia Celecoxib Revenue (2021-2032) & (US$ Million) Table 180. Taiwan Celecoxib Revenue (2021-2032) & (US$ Million) Table 181. Southeast Asia Celecoxib Revenue (2021-2032) & (US$ Million) Table 182. SAMEA Celecoxib Revenue by Type (2021-2026) & (US$ Million) Table 183. SAMEA Celecoxib Revenue by Type (2027-2032) & (US$ Million) Table 184. SAMEA Celecoxib Sales by Type (2021-2026) & (K Units) Table 185. SAMEA Celecoxib Sales by Type (2027-2032) & (K Units) Table 186. SAMEA Celecoxib Sales Price by Type (2021-2026) & (US$/Unit) Table 187. SAMEA Celecoxib Sales Price by Type (2027-2032) & (US$/Unit) Table 188. SAMEA Celecoxib Revenue by Application (2021-2026) & (US$ Million) Table 189. SAMEA Celecoxib Revenue by Application (2027-2032) & (US$ Million) Table 190. SAMEA Celecoxib Sales by Application (2021-2026) & (K Units) Table 191. SAMEA Celecoxib Sales by Application (2027-2032) & (K Units) Table 192. SAMEA Celecoxib Sales Price by Application (2021-2026) & (US$/Unit) Table 193. SAMEA Celecoxib Sales Price by Application (2027-2032) & (US$/Unit) Table 194. SAMEA Celecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. SAMEA Celecoxib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. SAMEA Celecoxib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. SAMEA Celecoxib Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 198. SAMEA Celecoxib Sales by Country (2021-2026) & (K Units) Table 199. SAMEA Celecoxib Sales by Country (2027-2032) & (K Units) Table 200. SAMEA Celecoxib Sales Price by Country (2021-2026) & (US$/Unit) Table 201. SAMEA Celecoxib Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Brazil Celecoxib Revenue (2021-2032) & (US$ Million) Table 203. Argentina Celecoxib Revenue (2021-2032) & (US$ Million) Table 204. Chile Celecoxib Revenue (2021-2032) & (US$ Million) Table 205. Colombia Celecoxib Revenue (2021-2032) & (US$ Million) Table 206. Peru Celecoxib Revenue (2021-2032) & (US$ Million) Table 207. Saudi Arabia Celecoxib Revenue (2021-2032) & (US$ Million) Table 208. Israel Celecoxib Revenue (2021-2032) & (US$ Million) Table 209. UAE Celecoxib Revenue (2021-2032) & (US$ Million) Table 210. Turkey Celecoxib Revenue (2021-2032) & (US$ Million) Table 211. Iran Celecoxib Revenue (2021-2032) & (US$ Million) Table 212. Egypt Celecoxib Revenue (2021-2032) & (US$ Million) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Celecoxib Distributors List Table 216. Celecoxib Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Celecoxib Image Figure 2. Global Celecoxib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Celecoxib Market Size Share 2021 VS 2025 VS 2032 Figure 4. 50mg Image Figure 5. 100mg Image Figure 6. 200mg Image Figure 7. 400mg Image Figure 8. Global Celecoxib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Celecoxib Market Size Share 2021 VS 2025 VS 2032 Figure 10. Rheumatoid arthritis Image Figure 11. osteoarthritis Image Figure 12. Acute pain Image Figure 13. Musculoskeletal pain Image Figure 14. Other diseases Image Figure 15. Global Celecoxib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Celecoxib Revenue (2021-2032) & (US$ Million) Figure 17. Global Celecoxib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Celecoxib Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Celecoxib Revenue Market Share by Region (2021-2032) Figure 20. Global Celecoxib Sales (2021-2032) & (K Units) Figure 21. Global Celecoxib Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 22. Global Celecoxib Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Celecoxib Sales YoY (2021-2032) & (K Units) Figure 24. Europe Celecoxib Sales YoY (2021-2032) & (K Units) Figure 25. China Celecoxib Sales YoY (2021-2032) & (K Units) Figure 26. Asia (Excluding China) Celecoxib Sales YoY (2021-2032) & (K Units) Figure 27. South America, Middle East and Africa Celecoxib Sales YoY (2021-2032) & (K Units) Figure 28. Global Celecoxib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Celecoxib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Celecoxib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Celecoxib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Celecoxib Revenue Market Share by Type (2021-2032) Figure 34. Global Celecoxib Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 35. Global Celecoxib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Celecoxib Sales Market Share by Type (2021-2032) Figure 37. Global Celecoxib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Celecoxib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Celecoxib Revenue Market Share by Application (2021-2032) Figure 40. Global Celecoxib Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 41. Global Celecoxib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Celecoxib Sales Market Share by Application (2021-2032) Figure 43. North America Celecoxib Revenue Share by Type (2021-2032) Figure 44. North America Celecoxib Sales Share by Type (2021-2032) Figure 45. North America Celecoxib Revenue Share by Application (2021-2032) Figure 46. North America Celecoxib Sales Share by Application (2021-2032) Figure 47. North America Celecoxib Revenue Share by Country (2021-2032) Figure 48. North America Celecoxib Sales Share by Country (2021-2032) Figure 49. Europe Celecoxib Revenue Share by Type (2021-2032) Figure 50. Europe Celecoxib Sales Share by Type (2021-2032) Figure 51. Europe Celecoxib Revenue Share by Application (2021-2032) Figure 52. Europe Celecoxib Sales Share by Application (2021-2032) Figure 53. Europe Celecoxib Revenue Share by Country (2021-2032) Figure 54. Europe Celecoxib Sales Share by Country (2021-2032) Figure 55. China Celecoxib Revenue Share by Type (2021-2032) Figure 56. China Celecoxib Sales Share by Type (2021-2032) Figure 57. China Celecoxib Revenue Share by Application (2021-2032) Figure 58. China Celecoxib Sales Share by Application (2021-2032) Figure 59. Asia Celecoxib Revenue Share by Type (2021-2032) Figure 60. Asia Celecoxib Sales Share by Type (2021-2032) Figure 61. Asia Celecoxib Revenue Share by Application (2021-2032) Figure 62. Asia Celecoxib Sales Share by Application (2021-2032) Figure 63. Asia Celecoxib Revenue Share by Country (2021-2032) Figure 64. Asia Celecoxib Sales Share by Country (2021-2032) Figure 65. SAMEA Celecoxib Revenue Share by Type (2021-2032) Figure 66. SAMEA Celecoxib Sales Share by Type (2021-2032) Figure 67. SAMEA Celecoxib Revenue Share by Application (2021-2032) Figure 68. SAMEA Celecoxib Sales Share by Application (2021-2032) Figure 69. SAMEA Celecoxib Revenue Share by Country (2021-2032) Figure 70. SAMEA Celecoxib Sales Share by Country (2021-2032) Figure 71. Celecoxib Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Celecoxib Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 100mg
  • 200mg
  • 400mg
Applications
  • Rheumatoid arthritis
  • osteoarthritis
  • Acute pain
  • Musculoskeletal pain
  • Other diseases
Companies covered
  • Pfizer Inc
  • Teva
  • Mylan
  • Apotex
  • Lupin
  • Hengrui Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Celecoxib Market by Type
  3. 1.2.1 Global Celecoxib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 50mg
  5. 1.2.3 100mg
  6. 1.2.4 200mg
  7. 1.2.5 400mg
  8. 1.3 Celecoxib Market by Application
  9. 1.3.1 Global Celecoxib Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Rheumatoid arthritis
  11. 1.3.3 osteoarthritis
  12. 1.3.4 Acute pain
  13. 1.3.5 Musculoskeletal pain
  14. 1.3.6 Other diseases
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Celecoxib Market Dynamics
  1. 2.1 Celecoxib Industry Trends
  2. 2.2 Celecoxib Industry Drivers
  3. 2.3 Celecoxib Industry Opportunities and Challenges
  4. 2.4 Celecoxib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Celecoxib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Celecoxib Revenue by Region
  3. 3.2.1 Global Celecoxib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Celecoxib Revenue by Region (2021-2026)
  5. 3.2.3 Global Celecoxib Revenue by Region (2027-2032)
  6. 3.2.4 Global Celecoxib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Celecoxib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Celecoxib Sales by Region
  9. 3.4.1 Global Celecoxib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Celecoxib Sales by Region (2021-2026)
  11. 3.4.3 Global Celecoxib Sales by Region (2027-2032)
  12. 3.4.4 Global Celecoxib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Celecoxib Revenue by Manufacturers
  2. 4.1.1 Global Celecoxib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Celecoxib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Celecoxib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Celecoxib Sales by Manufacturers
  6. 4.2.1 Global Celecoxib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Celecoxib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Celecoxib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Celecoxib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Celecoxib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Celecoxib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Celecoxib Manufacturers, Product Type & Application
  13. 4.7 Global Celecoxib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Celecoxib Market CR5 and HHI
  16. 4.8.2 2025 Celecoxib Tier 1, Tier 2, and Tier 3
5 Celecoxib Market by Type
  1. 5.1 Global Celecoxib Revenue by Type
  2. 5.1.1 Global Celecoxib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Celecoxib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Celecoxib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Celecoxib Sales by Type
  6. 5.2.1 Global Celecoxib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Celecoxib Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Celecoxib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Celecoxib Price by Type
6 Celecoxib Market by Application
  1. 6.1 Global Celecoxib Revenue by Application
  2. 6.1.1 Global Celecoxib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Celecoxib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Celecoxib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Celecoxib Sales by Application
  6. 6.2.1 Global Celecoxib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Celecoxib Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Celecoxib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Celecoxib Price by Application
7 Company Profiles
  1. 7.1 Pfizer Inc
  2. 7.1.1 Pfizer Inc Company Information
  3. 7.1.2 Pfizer Inc Business Overview
  4. 7.1.3 Pfizer Inc Celecoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Inc Celecoxib Product Portfolio
  6. 7.1.5 Pfizer Inc Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva Celecoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Celecoxib Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Mylan
  14. 7.3.1 Mylan Company Information
  15. 7.3.2 Mylan Business Overview
  16. 7.3.3 Mylan Celecoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Celecoxib Product Portfolio
  18. 7.3.5 Mylan Recent Developments
  19. 7.4 Apotex
  20. 7.4.1 Apotex Company Information
  21. 7.4.2 Apotex Business Overview
  22. 7.4.3 Apotex Celecoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Apotex Celecoxib Product Portfolio
  24. 7.4.5 Apotex Recent Developments
  25. 7.5 Lupin
  26. 7.5.1 Lupin Company Information
  27. 7.5.2 Lupin Business Overview
  28. 7.5.3 Lupin Celecoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Lupin Celecoxib Product Portfolio
  30. 7.5.5 Lupin Recent Developments
  31. 7.6 Hengrui Medicine
  32. 7.6.1 Hengrui Medicine Company Information
  33. 7.6.2 Hengrui Medicine Business Overview
  34. 7.6.3 Hengrui Medicine Celecoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hengrui Medicine Celecoxib Product Portfolio
  36. 7.6.5 Hengrui Medicine Recent Developments
8 North America
  1. 8.1 North America Celecoxib Market Size by Type
  2. 8.1.1 North America Celecoxib Revenue by Type (2021-2032)
  3. 8.1.2 North America Celecoxib Sales by Type (2021-2032)
  4. 8.1.3 North America Celecoxib Price by Type (2021-2032)
  5. 8.2 North America Celecoxib Market Size by Application
  6. 8.2.1 North America Celecoxib Revenue by Application (2021-2032)
  7. 8.2.2 North America Celecoxib Sales by Application (2021-2032)
  8. 8.2.3 North America Celecoxib Price by Application (2021-2032)
  9. 8.3 North America Celecoxib Market Size by Country
  10. 8.3.1 North America Celecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Celecoxib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Celecoxib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Celecoxib Market Size by Type
  2. 9.1.1 Europe Celecoxib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Celecoxib Sales by Type (2021-2032)
  4. 9.1.3 Europe Celecoxib Price by Type (2021-2032)
  5. 9.2 Europe Celecoxib Market Size by Application
  6. 9.2.1 Europe Celecoxib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Celecoxib Sales by Application (2021-2032)
  8. 9.2.3 Europe Celecoxib Price by Application (2021-2032)
  9. 9.3 Europe Celecoxib Market Size by Country
  10. 9.3.1 Europe Celecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Celecoxib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Celecoxib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Celecoxib Market Size by Type
  2. 10.1.1 China Celecoxib Revenue by Type (2021-2032)
  3. 10.1.2 China Celecoxib Sales by Type (2021-2032)
  4. 10.1.3 China Celecoxib Price by Type (2021-2032)
  5. 10.2 China Celecoxib Market Size by Application
  6. 10.2.1 China Celecoxib Revenue by Application (2021-2032)
  7. 10.2.2 China Celecoxib Sales by Application (2021-2032)
  8. 10.2.3 China Celecoxib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Celecoxib Market Size by Type
  2. 11.1.1 Asia Celecoxib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Celecoxib Sales by Type (2021-2032)
  4. 11.1.3 Asia Celecoxib Price by Type (2021-2032)
  5. 11.2 Asia Celecoxib Market Size by Application
  6. 11.2.1 Asia Celecoxib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Celecoxib Sales by Application (2021-2032)
  8. 11.2.3 Asia Celecoxib Price by Application (2021-2032)
  9. 11.3 Asia Celecoxib Market Size by Country
  10. 11.3.1 Asia Celecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Celecoxib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Celecoxib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Celecoxib Market Size by Type
  2. 12.1.1 SAMEA Celecoxib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Celecoxib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Celecoxib Price by Type (2021-2032)
  5. 12.2 SAMEA Celecoxib Market Size by Application
  6. 12.2.1 SAMEA Celecoxib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Celecoxib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Celecoxib Price by Application (2021-2032)
  9. 12.3 SAMEA Celecoxib Market Size by Country
  10. 12.3.1 SAMEA Celecoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Celecoxib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Celecoxib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Celecoxib Value Chain Analysis
  2. 13.1.1 Celecoxib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Celecoxib Production Mode & Process
  6. 13.2 Celecoxib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Celecoxib Distributors
  9. 13.2.3 Celecoxib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst